chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Fatigue, Glossodynia, Headache, Hypoaesthesia
Clinical narrative: Hand numbness; Fatigue; Headache; Nausea; Tongue sores; Ear Pain; Arm Pain; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 17Apr2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included probiotics nos (MANUFACTURER UNKNOWN) for unknown indication and start date. The patient had no allergies to food, medication or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 27Mar2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021, the patient experienced hand numbness, fatigue, headache, nausea, tongue sores, ear pain and arm pain. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hand numbness, fatigue, headache, nausea, tongue sores, ear pain and arm pain were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: Hand numbness; Fatigue; Headache; Nausea; Tongue sores; Ear Pain; Arm Pain; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 17Apr2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included probiotics nos (MANUFACTURER UNKNOWN) for unknown indication and start date. The patient had no allergies to food, medication or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 27Mar2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021, the patient experienced hand numbness, fatigue, headache, nausea, tongue sores, ear pain and arm pain. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hand numbness, fatigue, headache, nausea, tongue sores, ear pain and arm pain were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Palpitations
Clinical narrative: Nausea followed by heart palpitations; Nausea followed by heart palpitations; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 19Apr2021 at 13:00 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 01:30 (as reported), the patient experienced nausea followed by heart palpitations. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea followed by heart palpitations was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: Debilitating dizziness with nausea/vomiting; Debilitating dizziness with nausea/vomiting; Debilitating dizziness with nausea/vomiting; This is a spontaneous report from a contactable nurse, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 18Apr2021 at 10:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, environmental asthma, hypothyroid, allergy to penicillin (PCN) and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included metformin (MANUFACTURER UNKNOWN), insulin (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN); all from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 28Mar2021 at 09:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation and took codeine (MANUFACTURER UNKNOWN), morphine (MANUFACTURER UNKNOWN), metronidazole (FLAGYL) and gentamicin (GENTAMYCIN); all on unknown date for unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 04:45,  about 18 hours after vaccination, the patient experienced debilitating dizziness with nausea/vomiting. This lasted 8 hours on 19Apr2021 and has lasted over 6 hours on 20Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event debilitating dizziness with nausea/vomiting was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Muscle twitching
Clinical narrative: Headache; Dizziness; Muscle twitching; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in the left arm on 12Mar2021 at 14:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, high blood pressure; both controlled. The patient had known allergies to an unspecified antibiotic but could not remember the name and had not taken for years. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), rosuvastatin calcium (CRESTOR), vitamin d nos (MANUFACTURER UNKNOWN) and "daily multi"; all taken for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 14Mar2021, 2 days after vaccine, the patient experienced headache, dizziness, muscle twitching. She was now (at the time of this report) 6 weeks out and still had some dizziness and sometimes a headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, dizziness and muscle twitching were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Influenza, Nausea
Clinical narrative: Mild uncontrollable shaking; Basic flu symptoms; Fever of 102; Chills; Headache; Nausea; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Apr2021 at 00:00 (at the age of 24-years-old), as a single dose for COVID-19 immunisation. Medical history included depression and anxiety. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included vilazodone hydrochloride (VIIBRYD), buspirone (MANUFACTURER UNKNOWN) and bupropion (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Mar2021 at 00:00 (at the age of 24-years-old), as a single dose for COVID-19 immunisation. On 19Apr2021 at 04:00, first day the patient experienced sore arm. On 20Apr2021, second day, the patient experienced fever of 102, chills, headache, nausea and basic flu symptoms. On 21Apr2021, third day, the patient experienced mild uncontrollable shaking with no more flu symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 20Apr2021, the patient underwent lab test and procedure which included body temperature and result was shown as 102 (units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event basic flu symptoms was recovered on 21Apr2021. The clinical outcome of the events sore arm, fever of 102, chills, headache, nausea and mild uncontrollable shaking were unknown at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Tremor
Clinical narrative: Mild uncontrollable shaking; Basic flu symptoms; Fever of 102; Chills; Headache; Nausea; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Apr2021 at 00:00 (at the age of 24-years-old), as a single dose for COVID-19 immunisation. Medical history included depression and anxiety. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included vilazodone hydrochloride (VIIBRYD), buspirone (MANUFACTURER UNKNOWN) and bupropion (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Mar2021 at 00:00 (at the age of 24-years-old), as a single dose for COVID-19 immunisation. On 19Apr2021 at 04:00, first day the patient experienced sore arm. On 20Apr2021, second day, the patient experienced fever of 102, chills, headache, nausea and basic flu symptoms. On 21Apr2021, third day, the patient experienced mild uncontrollable shaking with no more flu symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 20Apr2021, the patient underwent lab test and procedure which included body temperature and result was shown as 102 (units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event basic flu symptoms was recovered on 21Apr2021. The clinical outcome of the events sore arm, fever of 102, chills, headache, nausea and mild uncontrollable shaking were unknown at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Erythema, Fatigue, Feeling abnormal, Feeling hot
Clinical narrative: gained 3 pounds water weight; tired; Immediate pain upon injection; nose breathing very restrictive; Huge weird rush from neck and entire head; Very high heart rate and blood pressure; Very high heart rate and blood pressure; Very red face; Very hot in head, fever like feeling; Very hot in head, fever like feeling; very foggy in head; random sharp pains over body; on and off headache pain; face puffy; cold; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 58-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Left on 19Apr2021 at 09:15 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunization (at the age of 58-years-old). Medical history included hashimoto's hypothyroidism from an unknown date and unknown if ongoing, Covid-19 (March-April 2020 sick with Covid19), allergies to some pain medicines and to some antibiotics from an unknown date and unknown if ongoing. Concomitant medication(s) included ibuprofen; colecalciferol (VIT D [COLECALCIFEROL]); cyanocobalamin (VIT B12); DHEA (5mg) and Thyroid medicine all were taken for an unspecified indication, start and stop date were not reported. Patient reported that Immediate after receiving the first dose of vaccine on 19Apr2021 at 09:15 pain upon injection and a minute or less, nose breathing very restrictive. Huge, weird rush from neck and entire head, feeling that she better lay down. Very high heart rate and blood pressure. Very red face. Very hot in head, fever like feeling. 1 hour after on 19Apr2021 had very foggy in head, random sharp pains over body, on and off headache pain, face puffy, cold. Next day on 20Apr2021 gained 3 pounds water weight and tired. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment on site nurse area to treat the events. Patient had no covid prior vaccination. Not tested for covid post vaccination. The patient was recovering from the events at the time of report.  No follow-up attempts are needed: information about lot/batch number/expiry date cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate increased, Hypertension, Nasopharyngitis, Pain
Clinical narrative: gained 3 pounds water weight; tired; Immediate pain upon injection; nose breathing very restrictive; Huge weird rush from neck and entire head; Very high heart rate and blood pressure; Very high heart rate and blood pressure; Very red face; Very hot in head, fever like feeling; Very hot in head, fever like feeling; very foggy in head; random sharp pains over body; on and off headache pain; face puffy; cold; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 58-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Left on 19Apr2021 at 09:15 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunization (at the age of 58-years-old). Medical history included hashimoto's hypothyroidism from an unknown date and unknown if ongoing, Covid-19 (March-April 2020 sick with Covid19), allergies to some pain medicines and to some antibiotics from an unknown date and unknown if ongoing. Concomitant medication(s) included ibuprofen; colecalciferol (VIT D [COLECALCIFEROL]); cyanocobalamin (VIT B12); DHEA (5mg) and Thyroid medicine all were taken for an unspecified indication, start and stop date were not reported. Patient reported that Immediate after receiving the first dose of vaccine on 19Apr2021 at 09:15 pain upon injection and a minute or less, nose breathing very restrictive. Huge, weird rush from neck and entire head, feeling that she better lay down. Very high heart rate and blood pressure. Very red face. Very hot in head, fever like feeling. 1 hour after on 19Apr2021 had very foggy in head, random sharp pains over body, on and off headache pain, face puffy, cold. Next day on 20Apr2021 gained 3 pounds water weight and tired. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment on site nurse area to treat the events. Patient had no covid prior vaccination. Not tested for covid post vaccination. The patient was recovering from the events at the time of report.  No follow-up attempts are needed: information about lot/batch number/expiry date cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Swelling face, Vaccination site pain, Weight increased
Clinical narrative: gained 3 pounds water weight; tired; Immediate pain upon injection; nose breathing very restrictive; Huge weird rush from neck and entire head; Very high heart rate and blood pressure; Very high heart rate and blood pressure; Very red face; Very hot in head, fever like feeling; Very hot in head, fever like feeling; very foggy in head; random sharp pains over body; on and off headache pain; face puffy; cold; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 58-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Left on 19Apr2021 at 09:15 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunization (at the age of 58-years-old). Medical history included hashimoto's hypothyroidism from an unknown date and unknown if ongoing, Covid-19 (March-April 2020 sick with Covid19), allergies to some pain medicines and to some antibiotics from an unknown date and unknown if ongoing. Concomitant medication(s) included ibuprofen; colecalciferol (VIT D [COLECALCIFEROL]); cyanocobalamin (VIT B12); DHEA (5mg) and Thyroid medicine all were taken for an unspecified indication, start and stop date were not reported. Patient reported that Immediate after receiving the first dose of vaccine on 19Apr2021 at 09:15 pain upon injection and a minute or less, nose breathing very restrictive. Huge, weird rush from neck and entire head, feeling that she better lay down. Very high heart rate and blood pressure. Very red face. Very hot in head, fever like feeling. 1 hour after on 19Apr2021 had very foggy in head, random sharp pains over body, on and off headache pain, face puffy, cold. Next day on 20Apr2021 gained 3 pounds water weight and tired. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment on site nurse area to treat the events. Patient had no covid prior vaccination. Not tested for covid post vaccination. The patient was recovering from the events at the time of report.  No follow-up attempts are needed: information about lot/batch number/expiry date cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye irritation, Musculoskeletal chest pain, Pyrexia, Renal pain
Clinical narrative: Shaking; Pain in kidneys; Burning eyes; Cramps in ribcage; Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 09Apr2021 at 16:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included chlortalidone (MANUFACTURER UNKNOWN), quinapril (MANUFACTURER UNKNOWN), cyanocobalamin (VITAMIN B12), ascorbic acid (VITAMIN C), vitamin d not otherwise specified (NOS) (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN); all taken for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 22Mar2021 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. On 10Apr2021 at 05:00, the patient experienced fever, chills, shaking, pain in kidneys, burning eyes, and cramps in the ribcage. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of events which included treatment with two ibuprofen (MANUFACTURER UNKNOWN) on 10Apr2021 at 16:00. The clinical outcome of the events fever, chills, shaking, pain in kidneys, burning eyes, and cramps in ribcage were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Shaking; Pain in kidneys; Burning eyes; Cramps in ribcage; Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 09Apr2021 at 16:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included chlortalidone (MANUFACTURER UNKNOWN), quinapril (MANUFACTURER UNKNOWN), cyanocobalamin (VITAMIN B12), ascorbic acid (VITAMIN C), vitamin d not otherwise specified (NOS) (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN); all taken for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 22Mar2021 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. On 10Apr2021 at 05:00, the patient experienced fever, chills, shaking, pain in kidneys, burning eyes, and cramps in the ribcage. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of events which included treatment with two ibuprofen (MANUFACTURER UNKNOWN) on 10Apr2021 at 16:00. The clinical outcome of the events fever, chills, shaking, pain in kidneys, burning eyes, and cramps in ribcage were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness in right side of face particularly cheek area.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 08Apr2021 at 14:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, arthritis and hypothyroidism. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included budesonide, formoterol fumarate (SYMBICORT) and triamcinolone acetonide (NASACORT), from an unknown date for unknown indication and unknown if on going. The patient previously took codeine (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On 08Apr2021 at 14:15, the patient experienced numbness in right side of face particularly cheek area. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of reported event. The clinical outcome of event, numbness in right side of face particularly cheek area was unknown at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Got the shot On 3/29/2021 on day 4 in the evening patient was sleeping and patient heart started racing really fast woke her up had to breath in and out to calm down to slow her heart rate; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 12:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, cholesterol and allergic to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included losartan potassium (LOZARTEN) used for unknown indication from unspecified dates, unknown if ongoing. The patient previously received pethidine hydrochloride (DEMEROL) and experienced drug allergy. On 02Apr2021 at 22:30, in the evening, the patient was sleeping and her heart started racing really fast, she woke up, had to breath in and out to calm down to slow her heart rate. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event heart started racing really fast, she woke up, had to breath in and out to calm down to slow her heart rate was recovered on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash pruritic, SARS-CoV-2 test
Clinical narrative: Toes became sore; Toes became itchy; Left hand broke out in itchy rash; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 13:00 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), paroxetine hydrochloride (PAXIL); both from an unknown date for unknown indication and unknown if ongoing.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 02:00 the patient experienced toes became sore and itchy, left hand broke out in itchy rash.  The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with topical cream. On 30Mar2021, the patient underwent Nasal Swab, SARS CoV-2 test and the result was Negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events toes became sore, toes became itchy and left hand broke out in itchy rash were resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Paraesthesia
Clinical narrative: Upon receiving the injection I had a metallic taste in my mouth.; chin, right cheek, right temple, rightside of my neck and right upper armshad pins and needles that lastedhours; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 20Apr2021 at 08:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. The patient did not have any allergies to medications, food, or other products. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol; etonogestrel (NUVARING). On 20Apr2021 at 08:15, upon receiving the injection, the patient experienced a metallic taste in mouth and chin, right cheek, right temple, right side of neck and right upper arms had pins and needles that lasted hours. Therapeutic measures were not taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event had a metallic taste in mouth and chin, right cheek, right temple, right side of neck and right upper arms had pins and needles hours was recovered in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pain, Pruritus
Clinical narrative: itching in the upper chest, breasts, armpits; Nausea; headache; Body aches; Chills; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old patient of unspecified gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 10Mar2021 at 12:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, panic disorder and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included sertraline hydrochloride (ZOLOFT) for an unknown indication from an unknown date, unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810) via an unspecified route of administration in the right arm on 17Feb2021 at 12:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. On 11Mar2021 at 02:00, the patient experienced itching in the upper chest, breasts, armpits, nausea, headache, body aches and chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events itching in the upper chest, breasts, armpits, nausea, headache, body aches and chills was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Hyperglycaemia, SARS-CoV-2 test
Clinical narrative: hyperglycaemia; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 16:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient medical history included diabetes (continued to produce insulin though).The patient had no known allergies. Concomitant medications included metformin (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and lisinopril dihydrate (LISI). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Mar2021 at 16:00 hours (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.Since the vaccination, the patient was tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 15:00, the patient's experienced hyperglycemia. The patient sugar was very high and continued to be high during the week of this report which was getting better. On an unknown date in Apr2021, the patient underwent blood sugar test and the result was 300. On an unknown date in Apr2021, the patient underwent blood sugar level and the result was 160 to 180. On 07Jul2020, the patient underwent COVID-19 test (nasal swab) and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of adverse events. The clinical outcome of the event hyperglycemia and sugar was very high was resolving  at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Flushing, Heart rate, Heart rate increased
Clinical narrative: Entire body feeling hot; Face flushing; Increased heart rate; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 13Apr2021 at 17:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin d (MANUFACTURER UNKNOWN), probiotics (unspecifed) and AREDS 2; all for unknown indications, from unknown date and unknown if ongoing. On 13Apr2021 at 18:00, the patient experienced entire body feeling hot, face flushing and increased heart rate. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events entire body feeling hot, face flushing and increased heart rate were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Vertigo
Clinical narrative: Intense feelings of dizziness.; Everything around head suddenly started to spin so fast for about a minute almost, couldn't even open eyes. Even with the eyes closed head didn't want to stop from spinning; get so dizzy and start losing balance that have to hold on something otherwise would fall; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 03:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on unknown date in 2019 (10 months prior to the vaccination). Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 03:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 04:00, the patient experienced Intense feelings of dizziness and everything around his head suddenly started to spin so fast for about a minute almost and he couldn't even open his eyes. Even with the eyes closed his head didn't want to stop from spinning. Then after few minutes got better but he still couldn't look up or down or a turn to the right or left. Even after almost 12 hours he could not turn his head up or down or to side. He got so dizzy and started losing balance that he had to hold on something otherwise would fall and turning the head up or down was the worst case with much more dizziness and spinning of the head. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event Intense feelings of dizziness, head spinning and started losing balance that he had to hold on something otherwise would fall was resolved with sequelae on 20Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen Supraclavicular Lymph Node 24 hours after injection.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 19Apr2021 at 14:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included ulcerative colitis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included nicotine (patches) (MANUFACTURER UNKNOWN) taken for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EA8730) via an unspecified route of administration in the right arm on 29Mar2021 at 14:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 20Apr2021 at 14:00, the patient experienced swollen supraclavicular lymph node 24 hours after injection. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen supraclavicular lymph node was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Palpitations
Clinical narrative: Heart palpitations; Headache; Dizziness; This is a spontaneous report from a contactable nurse, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm left on 19Apr2021 at 15:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included gluten sensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) taken for an unknown indication, since an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on 23Mar2021 at 16:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 19Apr2021, about an hour after vaccination, the patient experienced heart palpitations and lasted for about 4 hours intermittently. On 19Apr2021, on the same day of vaccination, the patient experienced severe headache and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the event heart palpitations was resolved on 19Apr2021. The clinical outcome of the events headache and dizziness was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia
Clinical narrative: Headache,  fever, nausea, body aches; fever; nausea; body aches; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 13:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was taking prescribed medication (unspecified) within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 13:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 00:00, the patient experienced headache, fever, nausea and body aches. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache, fever, nausea and body aches was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash
Clinical narrative: Redness and rash at injection site; Redness and rash at injection site; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 09Apr2021 at 16:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 19Apr2021 at 07:00, the patient experienced redness and rash at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of events redness and rash at injection site was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral coldness
Clinical narrative: Coldness in right arm immediately following injection and stayed cold for approximately 48 hours; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 17Apr2021 at 10:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included MS (multiple sclerosis). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included dexamethasone (DECADRON), heparin (MANUFACTURER UNKNOWN) and diazepam (MANUFACTURER UNKNOWN); all taken for unknown indications, from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 17Apr2021 at 10:00, the patient experienced coldness in right arm immediately following injection that stayed cold for approximately 48 hours. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event coldness in right arm immediately following injection and stayed cold for approximately 48 hours was resolved on 19Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.